Molina Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Molina Healthcare, Inc. on February 26, 2026. The filing serves as a Regulation FD disclosure regarding upcoming investor communications and the reaffirmation of the company's 2026 financial guidance.
Key Financial Metrics
The filing does not report historical revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on forward-looking earnings per share (EPS) targets for the full year 2026:
- 2026 Full Year GAAP Diluted EPS Guidance: At least $3.20
- 2026 Full Year Adjusted Diluted EPS Guidance: At least $5.00
Material Changes
There are no material changes to financial results reported in this document. The filing confirms that the 2026 guidance remains consistent with the guidance previously provided on February 6, 2026.
Guidance, Outlook, and Upcoming Events
Management plans to reaffirm the 2026 EPS guidance during upcoming investor meetings. Key upcoming dates include:
- TD Cowen's 46th Annual Health Care Conference: March 3, 2026 (Live webcast at 9:10 a.m. ET).
- First Quarter 2026 Earnings Release: After market close on April 22, 2026.
- Q1 2026 Earnings Conference Call: April 23, 2026, at 8:00 a.m. ET.
- 2026 Investor Day: May 8, 2026, beginning at 9:30 a.m. ET.
The filing includes a Safe Harbor Statement noting that forward-looking statements are subject to risks and uncertainties detailed in the company's 2025 Form 10-K.
Investor Verification Checklist
- Verify the reconciliation of adjusted diluted EPS to GAAP diluted EPS in the press release filed as Exhibit 99.1 on February 5, 2026.
- Review the "Risk Factors" and "Forward-Looking Statements" sections of the 2025 Form 10-K for potential risks to the 2026 guidance.
- Monitor the Q1 2026 earnings release on April 22, 2026, for actual performance against the reaffirmed guidance.